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SUMMARY. Cabergoline (CAB) is a synthetic ergoline dopamine agonist with high affinity to D2 recep-
tors, thus used for the treatment of Parkinson’s patients and hyperprolactinemia disorders. In this study,
simple, fast, reliable and validated UV-VIS and 2nd order derivative spectrophotometric methods for de-
termination of CAB  in pharmaceutical preparations were developed without any previous sample prepa-
ration step. Determination of CAB  was performed at 280 nm wavelength by UV-VIS spectrophotometry
and in the range of 227-232 nm by 2nd order derivative spectrophotometry. Developed both spectrophoto-
metric methods were linear over the range of CAB  concentrations from 1 to 125 μg mL–1. The highest rel-
ative error and relative standard deviation in within-day and day-to-day study for UV-VIS spectropho-
tometry were found to be 1.10 % and 0.63 %, respectively. The relative error and relative standard devia-
tion in within-day and day-to-day study for 2nd order derivative spectrophotometry were not higher than
1.10 % and 0.70 %, respectively. 
